QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation: A Double-Blind, Randomized, Placebo-Controlled Trial

By Egstrup Kenneth  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 199-208

Adis International

Access to resources Recommend Favorite

Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

By Majewski Sebastian  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 179-188

Adis International

Access to resources Recommend Favorite

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

By Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Chrysant Steven G.  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 473-482

Adis International

Access to resources Recommend Favorite

Rationale for and Design of the CREATIVE-AF Trial: Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effect of Irbesartan on Oxidative Stress and Adhesion Molecules in Patients with Persistent Atrial Fibrillation

By Goette Andreas  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 565-572

Adis International

Access to resources Recommend Favorite